Oral evidence transcript
| Published on: | Tuesday 15 December 2015 |
|---|---|
| Date: | Monday 30 November 2015 |
| Meeting on: | Monday 30 November 2015 |
| Part of event segment: | Untitled |
| Document ID: | 154220 |
| Citations: |
|
Committees
Work packages
- Tuesday 3 November 2015 - Thursday 12 May 2016
Witnesses
-
Mark Hicken, Managing Director, Johnson and Johnson, Deb Lancaster, Director of Market Access, Roche, and Harpal Kumar, Chief Executive, Cancer Research UK; Will Cavendish, Director General, Innovation, Growth and Technology, Department of Health, Simon Stevens, Chief Executive, and Professor Peter Clark, Chair of the Cancer Drugs Fund, NHS England, and Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence (at 4.30pm).